Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer

Hua Hsi Wu, Peng Hui Wang, Jiun Yih Yeh, Yi Jen Chen, Ming Shyen Yen, Rui Lan Huang, Yueh Ju Tsai, Chiou Chung Yuan

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Objectives: Cytokeratin 19 is significant for indicating cancer cells, and Cyfra 21-1 is a fragment of cytokeratin 19. This retrospective study was designed to define the prognostic value of serum Cyfra 21-1 in epithelial ovarian cancers (EOC). Materials and methods: Serum Cyfra 21-1 concentration was obtained from 42 patients with EOC prior to treatment. Various prognostic aspects were examined using univariable and multivariable analyses. The standard serum marker cancer antigen 125 was measured simultaneously and compared in this analysis. Results: Serum levels of both Cyfra 21-1 and cancer antigen 125 were associated with positive retroperitoneal lymph nodes and platinum resistance; higher levels of Cyfra 21-1 (3.0ng/mL as the cut-off) were associated with shorter disease-free survival (16 months vs. 28 months, p=0.001) and overall survival (29 months vs. 41 months, p=0.007) than lower levels. Further univariable analysis showed that Cyfra 21-1, poor differentiation, and retroperitoneal lymph node metastasis were related to platinum resistance and mortality. Multivariable analysis indicated retroperitoneal lymph node metastasis and serum Cyfra 21-1 were independent risk factors for both disease-free survival and overall survival. Conclusion: The pretreatment level of serum Cyfra 21-1 had remarkable prognostic significance for EOC, indicating poor survival when it was elevated above 3.0ng/mL.

Original languageEnglish
Pages (from-to)30-34
Number of pages5
JournalTaiwanese Journal of Obstetrics and Gynecology
Issue number1
Publication statusPublished - 2014


  • Cyfra 21-1
  • Cytokeratin 19 fragment
  • Epithelial ovarian cancer
  • Prognosis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • General Medicine


Dive into the research topics of 'Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this